Postby Rock_Robster » Sat Feb 11, 2023 8:39 pm
I had a PVE which was fine - short anesthetic and a little sore, kind of felt like I’d been punched in the side for a day or so.
The liver resections(s) are obviously much larger, and will depend a lot on how much liver you’re having removed, and whether it’s open or laparoscopic? Mind were about 25% each and open; I was in hospital for 4-5 days each time, pretty useless for about 2 weeks. By 4 weeks I felt a lot better, and after 6 weeks back to work (desk job). Good pain meds are essential, along with breathing and walking exercises to reduce complications. Ask if you hospital has an ERAS program (Enhanced Recovery After Surgery), if not you can always do your own.
I had a urinary catheter (removed immediately), one drain (removed after a few days), an arterial line in my arm and central line in my neck (both removed when I left ICU), an IV line (removed when I went to oral painkillers), a pain buster local anaesthetic infusion (removed after 2 days), and nasal oxygen cannula (removed after a few days).
My broader question is around a PVE in your case. The challenge with a PVE is you usually have to wait at least 4-8 weeks afterwards for the full hypertrophy response, and you’ll likely also be off chemo for at least a month after a liver resection. The PVE itself can also create a pro-metastatic environment in the liver, with increased blood flow, inflammation, etc. Unfortunately quite a few patients (myself included) experience disease progression during the PVE phase which means resection can’t be completed. The usual way to reduce the risk of this is have “systemic control” of disease via chemotherapy beforehand. However you mentioned your chemo “didn’t work” - do we take this to mean you currently have progressive disease? In this case the risk of progression during PVE is likely higher again.
This is a tricky situation as I do think having the PVE and resection is likely your best path to NED and long-term survival. However often you only really get one shot at this procedure, so you want to give it the best chance of success. Given it sounds like you’ve had FOLFOX (good response) and have progressed on Xeloda monotherapy (probably unsurprising), you could weigh up the benefits of perhaps trying FOLFIRI before the PVE to reduce the risk of metastatic spread. Of course the risk of this is if you don’t respond to the FOLFIRI, then progression could rule out the resection.
Good luck whatever you decide and may you have the best outcome possible.
41M Australia
2018 Dx RC
G2 EMVI LVI, 4 liver mets
pT3N1aM1a Stage IVa MSS NRAS G13R
CEA 14>2>32>16>19>30>140>70
11/18 FOLFOX
3/19 Liver resection
5/19 Pelvic IMRT
7/19 ULAR
8/19 Liver met
8/19 FOLFOX, FOLFOXIRI, FOLFIRI
12/19 Liver resection
NED 2 years
11/21 Liver met, PALN, lung nodules
3/22 PVE, lymphadenectomy, liver SBRT
10/22 PALN SBRT
11/22 Liver mets, peri nodule. Xeloda+Bev
4/23 XELIRI+Bev
9/23 ATRIUM trial
12/23 Modified FOLFIRI+Bev
3/24 VAXINIA (CF33 + hNIS) trial